RUO
Metabolic
AOD-9604
Tyr-hGH (177-191)
≥98% (HPLC) CoA
from $42.00
Details
Illustrative rendering
Product photography is in preparation. The rendering above is illustrative and shows the research-use labelling applied to every vial we dispatch.
Tirzepatide
Also known as GIP/GLP-1 Dual Receptor Agonist
A synthetic dual GIP and GLP-1 receptor agonist built on a GIP backbone with Aib substitutions and a C-20 fatty diacid. Supplied as an analytical reference material for comparative incretin receptor research.
Research Use Only. All products sold by Genexis Health are intended strictly for in-vitro laboratory research and analytical purposes conducted by qualified professionals. They are not drugs, foods, cosmetics, dietary supplements or medical devices. They have not been evaluated or approved by the FDA, MHRA, EMA or any other regulatory authority for the diagnosis, treatment, cure or prevention of any disease. They must not be administered to humans or animals under any circumstance, and must not be resold, relabelled or repackaged for such use.
Additional regulatory notice.
This compound corresponds to an approved or investigational pharmaceutical substance in one or more jurisdictions. It is supplied here solely as an analytical reference material for laboratory research. Purchasers are responsible for confirming that possession and use for research purposes is lawful where they are located, and for holding any licence or institutional approval that may be required. Genexis Health does not supply this material for clinical, diagnostic, compounding or personal use of any kind.
Where this compound appears in the literature
A synthetic dual GIP and GLP-1 receptor agonist built on a GIP backbone with Aib substitutions and a C-20 fatty diacid. Supplied as an analytical reference material for comparative incretin receptor research.
The areas below describe the experimental contexts in which Tirzepatide is cited. They are provided to help you assess whether the material suits your assay. They are not claims of effect, and nothing here should be read as suggesting any use in humans or animals.
- Dual GIP / GLP-1 receptor selectivity assays
- Biased agonism and receptor trafficking research
- Analytical reference standard for LC-MS quantification
Genexis Health does not provide research protocols, dosing guidance, administration instructions or interpretation of results. Experimental design is the responsibility of the purchasing laboratory and its ethics or safety committee.
Storage
Store lyophilised powder at -20 °C, protected from light.
Solubility
Soluble in sterile water at neutral to slightly alkaline pH.
Laboratory handling
Allow the sealed vial to equilibrate to room temperature before opening to avoid condensation onto the lyophilised material. Prepare stock solutions using appropriate aseptic technique in a suitable containment environment, and label all derived solutions with the compound, concentration, date and the research-use restriction.
Handle as you would any uncharacterised research chemical: laboratory coat, gloves and eye protection, no eating or drinking in the work area, and no handling outside a controlled laboratory environment.
Disposal
Dispose of unused material, solutions and contaminated consumables through your institution's chemical waste stream in accordance with local regulations. Do not dispose of research materials in general waste or to drain.
Research Use Only. For laboratory research use only. Not for human or veterinary consumption.
Certificate of Analysis
Each lot of Tirzepatide is released with a Certificate of Analysis recording the lot number, HPLC purity chromatogram, mass spectrometry identity confirmation, appearance, and the date of analysis. The CoA for the current lot is available on request before purchase — email research@genexishealth.uk quoting the product name.
Safety data
A Safety Data Sheet is available for every catalog item. Research peptides are generally supplied as lyophilised solids with limited published toxicological data; treat any compound without a full hazard profile as potentially harmful and assess it under your own institutional risk assessment process.
Requesting documentation
Email research@genexishealth.uk with the product name and, where you already hold stock, the lot number printed on the vial. We retain analytical records for five years from the date of release.
Conditions of supply
Tirzepatide is sold subject to our Terms & Conditions and Research Use Only Policy. By placing an order you represent and warrant that:
- You are at least 21 years of age.
- You are acquiring the material for in-vitro laboratory research, or on behalf of an organisation that does so.
- You will not administer the material to a human or an animal, and will not transfer it to any person you believe intends to do so.
- You will comply with every law, licence, permit and institutional approval that applies to the material where you are located.
- You will store, handle and dispose of the material safely and lawfully once it leaves our custody.
Our right of refusal
We may refuse, cancel or refund any order at our discretion, including where a stated research purpose is missing or implausible, where an enquiry indicates intended human use, or where supply would breach any applicable restriction. See Compliance & Prohibited Use.
No warranty of fitness
Material is supplied to the specification on its Certificate of Analysis. Beyond that specification we give no warranty, express or implied, of fitness for any particular purpose. Determining suitability for your experiment is your responsibility.
Related research area